From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Acetaminophen a Risk Factor for Overanticoagulation.

Aspirin and NSAIDs are relatively contraindicated for patients who must use warfarin for long-term anticoagulation, but this case-control study suggests that the alternative analgesic acetominophen may not be completely safe.

The investigators interviewed 93 patients treated in an outpatient anticoagulant therapy unit who developed international normalized ratios (INRs) greater than 6.0 while on chronic warfarin therapy. One hundred ninety-six controls were selected from those whose INRs were between 1.7 and 3.3. Acetaminophen ingestion was independently associated with greater risk for an INR over 6.0, with adjusted odds ratios of 3.5 for those who used 7 to 13 tablets per week, 6.9 for those who used 14 to 27 tablets per week, and 10.0 for those who used 28 or more tablets per week. Other factors independently associated with an increased risk for an elevated INR were advanced malignancy (adjusted odds ratio, 16.4), newly started potentiating medication (8.5), warfarin dose more than predicted (8.1), decreased oral intake (3.6), and acute diarrheal illness (3.5). Consumption of alcohol and foods rich in vitamin K were inversely correlated with an INR greater than 6.0.

Comment: These data demonstrate that several factors can cause marked shifts in anticoagulation status, and that INRs should be monitored with caution during such exposures. How acetaminophen potentiates warfarin is not clear.

— TH Lee

Published in Journal Watch General Medicine March 13, 1998

Citation(s):

Hylek EM et al. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998 Mar 4 279 657-662.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1998. Massachusetts Medical Society. All rights reserved.